Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Bayview Acquisition | BAYA | Nov 13, 2024 | 10.63 | 0.00 |
BBB Foods | TBBB | Nov 13, 2024 | 32.96 | +0.21 |
BCB Bank | BCBP | Nov 13, 2024 | 13.26 | -0.38 |
BCE | BCE | Nov 13, 2024 | 27.21 | -1.73 |
Beachbody A | BODI | Nov 13, 2024 | 6.43 | -0.62 |
Beacon Roofing Supply | BECN | Nov 13, 2024 | 102.38 | -1.42 |
Beam Global | BEEM | Nov 13, 2024 | 4.23 | -3.64 |
Beam Therapeutics | BEAM | Nov 13, 2024 | 27.50 | -1.57 |
Beamr Imaging | BMR | Nov 13, 2024 | 2.73 | -4.55 |
Beasley Broadcast A | BBGI | Nov 13, 2024 | 8.22 | -4.61 |
Beazer Homes USA | BZH | Nov 13, 2024 | 31.96 | -0.31 |
Becton, Dickinson And Co | BDX | Nov 13, 2024 | 231.22 | -0.02 |
BeiGene ADR | BGNE | Nov 13, 2024 | 195.45 | +0.93 |
Bel Fuse A | BELFA | Nov 13, 2024 | 93.84 | -4.99 |
Bel Fuse B | BELFB | Nov 13, 2024 | 76.48 | -4.23 |
Belden | BDC | Nov 13, 2024 | 121.27 | -2.08 |
Belgium Investable Mkt Idx MSCI Ishares | EWK | Nov 13, 2024 | 19.16 | -0.31 |
Belite Bio ADR | BLTE | Nov 13, 2024 | 82.23 | +1.33 |
Bellevue Life Sciences Acquisition | BLAC | Nov 13, 2024 | 11.01 | -0.36 |
Bellevue Life Sciences Acquisition Unit | BLACU | Nov 13, 2024 | 10.95 | 0.00 |
BellRing Brands | BRBR | Nov 13, 2024 | 72.14 | +0.50 |
Belpointe Prep A | OZ | Nov 13, 2024 | 69.50 | -0.14 |
Benchmark Electronics | BHE | Nov 13, 2024 | 48.46 | -2.79 |
Beneficient A | BENF | Nov 13, 2024 | 1.25 | -3.10 |
Benitec Biopharma | BNTC | Nov 13, 2024 | 10.44 | -3.96 |
Benson Hill | BHIL | Nov 13, 2024 | 6.43 | -0.31 |
Bentley Systems B | BSY | Nov 13, 2024 | 48.43 | -1.96 |
Berkshire Hathaway A | BRK-A | Nov 13, 2024 | 702 250.00 | +0.22 |
Berkshire Hathaway B | BRK-B | Nov 13, 2024 | 468.10 | +0.39 |
Berkshire Hills Bancorp | BHLB | Nov 13, 2024 | 30.99 | -0.80 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.